Bio-Rad Laboratories (NYSE:BIO) & Hybrid Energy (OTCMKTS:HYBE) Head to Head Analysis

Bio-Rad Laboratories (NYSE:BIO) and Hybrid Energy (OTCMKTS:HYBE) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

Analyst Recommendations

This is a summary of current ratings and target prices for Bio-Rad Laboratories and Hybrid Energy, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Rad Laboratories	1	3	1	0	2.00
Hybrid Energy	0	0	0	0	0.00

Bio-Rad Laboratories presently has a consensus target price of $303.33, suggesting a potential upside of 2.06%. Given Bio-Rad Laboratories’ stronger consensus rating and higher probable upside, equities research analysts clearly believe Bio-Rad Laboratories is more favorable than Hybrid Energy.

Earnings and Valuation

This table compares Bio-Rad Laboratories and Hybrid Energy”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Rad Laboratories	$2.58 billion	3.08	$759.90 million	$6.07	48.96
Hybrid Energy	N/A	N/A	N/A	N/A	N/A

Bio-Rad Laboratories has higher revenue and earnings than Hybrid Energy.

Profitability

This table compares Bio-Rad Laboratories and Hybrid Energy’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bio-Rad Laboratories	6.52%	3.56%	2.49%
Hybrid Energy	N/A	N/A	N/A

Insider & Institutional Ownership

65.2% of Bio-Rad Laboratories shares are owned by institutional investors. 30.3% of Bio-Rad Laboratories shares are owned by company insiders. Comparatively, 6.0% of Hybrid Energy shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Bio-Rad Laboratories beats Hybrid Energy on 9 of the 9 factors compared between the two stocks.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

About Hybrid Energy

Hybrid Energy Holdings, Inc., through its subsidiaries, acquires and operates fuel production and other energy companies. It acquires companies with traditional and proven fuel production, photovoltaic (PV) and solar thermal technologies. Hybrid Energy Holdings, Inc. was formerly known as Comprehensive Healthcare Solutions, Inc. and changed its name to Hybrid Energy Holdings, Inc. in September 2009. Hybrid Energy Holdings, Inc. was incorporated in 1966 and is based in Reno, Nevada. Hybrid Energy Holdings, Inc. is in reorganization.